S&P 500
(-1.43%) 4 339.25 points
Dow J
(-0.93%) 34 120 points
(-1.53%) 13 263 points
(0.03%) $89.69
(-3.11%) $2.65
(-1.32%) $1 941.10
(-0.57%) $23.70
(-1.76%) 925.70
(0.03%) 0.938
(-0.07%) 10.77
(0.40%) 0.813
(0.15%) 96.16

Realtime updates for Propanc Biopharma, Inc. [PPCB]

Exchange: PNK Industry: Biotechnology
Last Updated21 Sep 2023 @ 15:27

-6.89% $ 0.0250

Live Chart Being Loaded With Signals

Propanc Biopharma, Inc., a biopharmaceutical company, develops cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia...

Today's Volume 416 694
Average Volume 460 166
Market Cap 82.21B
EPS $-0.0011
Earnings date 2022-11-14
P/E -2.50
ATR14 $0.0010 (4.17%)

Propanc Biopharma, Inc. Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Propanc Biopharma, Inc. Financials

Annual 2022
Revenue: $0
Gross Profit: $-28 366.00 (0.00%)
EPS: $-0.0390
Q3 2023
Revenue: $0
Gross Profit: $-8 365.00 (0.00%)
EPS: $-0.420
Q2 2023
Revenue: $0
Gross Profit: $-7 506.00 (0.00%)
EPS: $-0.0005
Q1 2023
Revenue: $0
Gross Profit: $-6 373.00 (0.00%)
EPS: $-0.0011

Propanc Biopharma, Inc.

Propanc Biopharma, Inc., a biopharmaceutical company, develops cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. Its lead product is PRP, a formulation that is in preclinical phase of development designed to enhance the anti-cancer effects of multiple enzymes. The company has a research collaboration with University of Jaén that undertakes the research activities for POP1 joint drug discovery program; and a joint research and drug discovery program with Universities of Jaén and Granada to investigate the changes in genetic and protein expression that occur in cancer cells. The company was formerly known as Propanc Health Group Corporation and changed its name to Propanc Biopharma, Inc. in April 2017. Propanc Biopharma, Inc. was incorporated in 2007 and is based in Camberwell, Australia.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators


"Getagraph.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "Getagraph.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.
Total Execution Time: 2.4003250598907 seconds
Number of API calls: 1
Number of DB calls: 8